Press coverage about LHC Group (NASDAQ:LHCG) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. LHC Group earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the health services provider an impact score of 45.4833789130286 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

LHC Group (LHCG) traded up $3.31 on Wednesday, hitting $71.29. 271,030 shares of the company were exchanged, compared to its average volume of 142,286. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. LHC Group has a 52 week low of $41.66 and a 52 week high of $76.14. The stock has a market cap of $1,215.92, a PE ratio of 28.55, a price-to-earnings-growth ratio of 1.97 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last released its earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The company had revenue of $272.90 million for the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter in the previous year, the company earned $0.54 EPS. LHC Group’s revenue for the quarter was up 18.2% on a year-over-year basis. equities research analysts anticipate that LHC Group will post 2.4 EPS for the current year.

LHCG has been the subject of a number of recent research reports. SunTrust Banks, Inc. reissued a “buy” rating and set a $75.00 price objective on shares of LHC Group in a research report on Friday, November 3rd. BidaskClub downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Jefferies Group LLC reissued a “buy” rating and set a $68.00 price objective on shares of LHC Group in a research report on Friday, August 4th. Robert W. Baird reissued a “hold” rating and set a $63.00 price objective on shares of LHC Group in a research report on Tuesday, September 12th. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $79.00 price objective for the company in a research report on Wednesday, November 8th. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. LHC Group has a consensus rating of “Buy” and an average target price of $76.90.

TRADEMARK VIOLATION NOTICE: “LHC Group (LHCG) Given News Sentiment Score of 0.17” was published by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/lhc-group-lhcg-given-news-sentiment-score-of-0-17/1720597.html.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the sale, the chief operating officer now owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 14.80% of the stock is owned by insiders.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.